We invest in, empower,
and help grow high potential
software & technology companies
Our investment philosophy is centered on the belief that software & technology are changing the world. We invest in companies that have interesting, protectable market share and are led by high-character, experienced founders who have a long-term perspective and a passion for the markets they serve.
Partners for Growth
We maintain a focused and disciplined approach to investing. Our aim is to create consistent value
while positioning our portfolio companies for long-term success. The firms in our portfolio are market leaders
in software, data, and technology.
MemberMax™
Let’s face it. Most people hate the software they use in their non-profit organization. At MemberMax™, we believe trade associations deserve better software - software that’s intuitive, easy to setup & use, and always available in the Cloud. All of our products live up to this promise and are backed by our world-class customer support team.
Qualtrax®
Qualtrax® works with companies worldwide to assist them with achieving compliance goals. This includes not only managing documentation, but automating key business processes, streamlining training management, and ensuring critical industry regulations are addressed.
gNext Labs
A cloud-based asset condition management platform used by major civil infrastructure owners to help make better operational decisions, reduce risks, and increase asset's performance.
CytoRecovery™
Creating innovative new capabilities to rapidly separate, and recover live cancer and other cell subpopulations from biological samples, in their native state, enabling unbiased, downstream cell biology analytics.
Acomhal Research
Creating innovative new capabilities to rapidly separate, and recover live cancer and other cell subpopulations from biological samples, in their native state, enabling unbiased, downstream cell biology analyticAcomhal Research Inc. is a biotech startup company co-founded by Dr. Samy Lamouille and Dr. Robert Gourdie at the Fralin Biomedical Research Institute at Virginia Tech Carilion. Acomhal Research is developing novel treatments targeting cancer cells that are resistant to therapy in order to prevent tumor recurrence and metastasis.
About Us
Bloomfield Partners, LLC was launched in 2014 to provide growth capital to software and innovation companies. We are a value-added investor who looks to be actively engaged with our portfolio companies. We have a patient, long-term investment philosophy that is not exclusively driven by the size of our investment return, but by making decisions that are in the long-term best interest of the founding entrepreneurs and their shareholders. Our managing partner is Kevin Bloomfield.
Kevin is a serial entrepreneur who is passionate about building healthy cultures, exceptional teams, and great products all while obsessing about customers. Prior to founding Bloomfield Partners, Kevin was CEO of NetVentures where he helped to build a fast-growing, disruptive cloud-based Operations & Fund Accounting software platform for progressive non-profit organizations. He led the company’s growth from an early-stage startup with just a handful of customers to the market leader with over 500 customers that processed over two billion dollars of customer transactions. In 2014, his company was acquired by the private equity firm Pamlico Capital.
KEVIN BLOOMFIELD
Managing Partner
Contact Us Today
Ready to start a conversation about a potential investment from Bloomfield Partners? Send us a message today.
P.O. Box 8372 Roanoke, VA 24014